Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Anixa Biosciences

HOPE GOLD PRKR ANIX CHEESE

HOPE How To Save The American Experiment It’s not at all clear we can — Putin has been winning for a long time now —...

Saving Advice · Oct 9, 2025

Woman who was first in world to receive breast cancer vaccine says its 'wonderful'

Nurse Jennifer Davis, from Ohio, US, was the first patient in the world to receive the Triple Negative Breast Cancer Vaccine in 2021 at the Cleveland Clinic, which has been in development for nearly twenty years

Daily Mirror · Jun 3, 2023

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga · Sep 16, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

Gritstone bio (NASDAQ:GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy candidate for solid tumor cancers, were published today in Nature Medicine. The initial results from the study are expected during second half of 2023. Gritstone shares traded in a range of $3.96 to $4.24…

Benzinga · Aug 15, 2022

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga · Apr 29, 2022

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Anixa Biosciences (NASDAQ:ANIX) stock moved upwards by 9.1% to $3.35 during Tuesday's after-market session. The company's market cap stands at $100.9 million.

Benzinga · Jan 25, 2022

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

US Food and Drug Administration

Medicines and Healthcare products Regulatory Agency

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.